Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Liraglutide for Sale > 99 Purity Peptides Powder Liraglutide CAS 204656-20-2
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - large image1
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image1
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image2
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image3
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image4
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image5
99 Purity Peptides Powder Liraglutide CAS 204656-20-2 buy - image6

99 Purity Peptides Powder Liraglutide CAS 204656-20-2

TDS 28 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

focuses

Packaging:

as requires

Price valid (until):

2025-05-09

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    white powder Liraglutide CAS 204656-20-2 API weight lose peptide Peptide 5mg/10mg/15mg Vials

    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 1

    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 2



    Items Specifications
    Name Liraglutide
    CAS Number    
    204656-20-2
    Appearance White or white crystalline powder
    Storage Temperature Keep in a cool, dry, dark location in a tightly sealed container or cylinder.

    How should I use Liraglutide CAS 204656-20-2 API?


    Liraglutide is injected under the skin at any time of the day, with or without a meal. A healthcare provider may teach you how to properly use the medication by yourself. Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.


    Prepare an injection only when you are ready to give it. Do not use if the medicine has changed colors or has particles in it. Call your pharmacist for new medicine.


    Call your doctor if you are sick with vomiting or diarrhea. You can easily become dehydrated while using liraglutide. This can lead to kidney failure.


    You may have low blood sugar (hypoglycemia) and feel very hungry, dizzy, irritable, confused, anxious, or shaky. To quickly treat hypoglycemia, eat or drink a fast-acting source of sugar (fruit juice, hard candy, crackers, raisins, or non-diet soda).

    Also watch for signs of high blood sugar (hyperglycemia) such as increased thirst or urination.
    Blood sugar levels can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals. Ask your doctor before changing your dose or medication schedule.


    Storing unopened injection pens: Refrigerate and use until the expiration date.

    Storing after your first use: Store the pen in a refrigerator or at room temperature and use within 30 days.
    Do not freeze liraglutide, and throw away the medicine if it has become frozen.
    Use a needle only once and then place it in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.


    Factors To Remember When Buying Liraglutide CAS 204656-20-2 API

    Consult a Healthcare Provider
    Schedule an appointment with a healthcare professional, preferably an endocrinologist or a primary care physician who specializes in diabetes or obesity. Discuss your medical history, current condition, and treatment goals.


    Consult a Healthcare Provider
    If your healthcare provider determines that Semaglutide or Liraglutide is suitable for your needs, they will prescribe the medication. This step is essential, as both drugs are available by prescription only.


    Insurance and Coverage
    Check with your health insurance provider to determine whether Semaglutide or Liraglutide is covered under your plan. These medications can be expensive and require proper storage, so understanding your coverage and potential out-of-pocket costs is crucial.


    Select a Pharmacy
    Once you have a prescription, choose a pharmacy where you'd like to buy the peptides. Many pharmacies offer the option to order medications online or in-store, providing flexibility based on your preferences.


    Fill the Prescription
    Take your prescription to the selected pharmacy and ask the pharmacist to fill it. They will provide you with the appropriate dosage and instructions for use. Be sure to ask any questions you may have about the medication, dosing, and potential side effects to ensure safe and effective use.


    Uses of Liraglutide CAS 204656-20-2 API


    Type 2 Diabetes Management
    Liraglutide serves as a pivotal agent in the management of type 2 diabetes, offering a multifaceted approach to glycemic control.
    Simultaneously, Liraglutide curtails the secretion of glucagon, a hormone that raises blood sugar levels, thereby assisting those with high blood pressure. These combined actions lead to improved glycemic control, helping to reduce elevated blood glucose levels characteristic of type 2 diabetes.


    Cardiovascular Risk Reduction
    Liraglutide has emerged as a potential champion in reducing cardiovascular risk among individuals with type 2 diabetes.
    Participants receiving Liraglutide experienced a notable decrease in the risk of major adverse cardiovascular events (MACE), encompassing heart attacks, strokes, and cardiovascular-related deaths. This risk reduction is particularly crucial for individuals with diabetes, as they are often at a heightened risk of cardiovascular complications.
    While the precise mechanisms underlying these cardiovascular benefits are not yet fully understood, Liraglutide's ability to improve blood sugar control, reduce blood pressure, and positively impact body weight likely contributes to its favorable cardiovascular outcomes.


    Neuroprotection
    Preclinical studies have provided tantalizing hints regarding Liraglutide's potential neuroprotective properties.
    While the majority of research remains at the experimental stage, Liraglutide has demonstrated neuroprotection in animal models of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.


    Polycystic Ovary Syndrome (PCOS)
    Although not yet widely accepted, Liraglutide has been explored as a treatment option for individuals with polycystic ovary syndrome (PCOS).
    PCOS is characterized by insulin resistance, hormonal imbalances, and weight gain. Liraglutide's ability to improve insulin sensitivity and promote weight reduction makes it a potentially beneficial option for managing PCOS.


    The Difference Between Semaglutide and Liraglutide


    Semaglutide is a remarkable peptide-based medication renowned for its effectiveness in managing type 2 diabetes and promoting weight loss.
    Firstly, it enhances insulin secretion from pancreatic beta cells, which helps regulate blood sugar levels, particularly after meals.
    Simultaneously, Semaglutide inhibits glucagon secretion, preventing the liver from releasing excess glucose into the bloodstream.
    Beyond its immediate glycemic effects, Semaglutide slows down gastric emptying, reducing energy intake and post-meal spikes in blood sugar.


    Moreover, it exerts a profound impact on appetite control centers in the brain, promoting satiety and reducing energy intake. This appetite-suppressing quality makes Semaglutide a valuable tool in obesity management.
    Semaglutide's multifaceted mechanism of action makes it a potent and versatile therapeutic option for individuals with type 2 diabetes and obesity, offering improved glycemic control and substantial weight loss benefits.


    All about Liraglutide
    Liraglutide, a remarkable peptide-based medication, functions as a potent agonist of the glucagon-like peptide-1 (GLP-1) receptor, playing a pivotal role in the management of type 2 diabetes and obesity management.
    Its mechanism of action is a multi-faceted process designed to address key issues in these chronic diseases.
    It operates by enhancing insulin secretion from pancreatic beta cells, suppressing glucagon release, and slowing down gastric emptying.
    Furthermore, Liraglutide exerts its influence on the hypothalamus, effectively curbing appetite and promoting a feeling of fullness. This appetite-suppressing effect contributes to the weight reduction observed in individuals using Liraglutide.
    Additionally, Liraglutide exhibits potential cardiovascular benefits, including reducing the risk of heart attacks and strokes. This makes it a valuable asset for individuals with diabetes, who often face an elevated risk of cardiovascular complications.


    5 Liraglutide Interactions and How to Manage Them


    Insulin

    Insulin is a hormone that's naturally made by the pancreas to regulate blood glucose levels. But certain people with Type 2 diabetes may need to take extra insulin. In this case, experts recommend combining insulin with a medication like liraglutide.
    Even though liraglutide is injected, it's not the same as insulin. Instead, it triggers insulin production after you've eaten to lower your blood glucose. When liraglutide and insulin are taken together, there is a chance your blood glucose could drop too low. This is known as hypoglycemia.

    Sulfonylureas

    Like liraglutide, sulfonylureas stimulate the release of insulin from the pancreas. But they have this effect even if you haven't eaten a meal. When a sulfonylurea is combined with liraglutide, this can increase the risk of hypoglycemia.
    Similar to insulin, your healthcare provider may lower your sulfonylurea dosage as you're starting liraglutide - just to be safe. But it's still important to monitor your blood glucose levels regularly with this combination. Let your healthcare provider know if you're experiencing hypoglycemia episodes. If needed, they may make further adjustments.

    Glinides

    Glinides are a class of medications similar to sulfonylureas. They also trigger insulin release, but they work faster and for a shorter time. So, they're typically taken only at mealtime. Nateglinide and repaglinide are two examples.
    Like sulfonylureas, combining a glinide with liraglutide can raise the risk of hypoglycemia. So, your healthcare provider may adjust your glinide dosage when you start liraglutide. Let them know if you're experiencing hypoglycemia, since additional adjustments may be needed.

    Oral medications

    One of the ways liraglutide works is by delaying gastric emptying. This means that food moves more slowly through your digestive tract. This is a beneficial effect in Type 2 diabetes because it prevents a spike in blood glucose. And it can also make you feel full, resulting in weight loss.
    However, delayed gastric emptying may also affect how your body absorbs oral medications. This can be a concern for narrow therapeutic index drugs (NTIs). A small change in your dose or blood levels can affect the effectiveness and safety of NTIs.

    Medications that increase blood glucose

    Certain medications can raise blood glucose levels. Examples include corticosteroids, like prednisone, and beta blockers, like metoprolol (Lopressor, Toprol XL). Antipsychotics such as olanzapine (Zyprexa) and clozapine (Clozaril) may also cause a bump in blood glucose
    Some of these medications are only taken for a short period of time. In this case, the rise in blood glucose is usually temporary and resolves after stopping the medication. But many of them are taken long-term. This may require a higher liraglutide dosage to get your blood glucose under control.


    Shop 99 Purity Peptides Powder Liraglutide CAS 204656-20-2-Detailed Image 3

    Our Factory

    Fujian Genohope Biotech Ltd was established in 2019, It was co-founded by New Hope  Hosencare Brothers  and Taiwan Genovior Biotech Corporation. The company is located in the national "Cross-Strait Biotechnology and Health and Medical Industry Cooperation Zone" in Putian City, Fujian Province. The company has 260 employees, and in 2023, the company was selected as a Specialized in special innovative enterprises in Fujian Province.

    The company focuses on High potency polypeptide API/solution, and sells polypeptide API/solution and preparation production services to the global market. The company covers a total area of 55 mu, with a total construction area of about 70,000 square meters, and has built about 800 square meters of R & D center, 1,000 square meters of  quality control center and 3,300 square meters of GMP production workshop. At present, 13 production  lines have been built, including 7 production lines for the preparation of recombinant peptide API and fully synthetic peptide API and 6 lines for injections. In addition, the company also has a large anti-tumor injection workshop, a small multi-purpose injection workshop, a large multi-purpose injection workshop. The construction and operation management of the production line meet the regulatory requirements of the global drug market and meet the double registration and declaration of China and the United States. Also can meet the customer registration and sales at home and abroad.

    Product superiority:

    At present, the company's main products are Semaglutide, Tirzepatide, Retatrutide, cosmetic medicine microspheres, collagen. In particular, the company has the advantage of mature 2 processes preparation of Semaglutide API, Semaglutide API registered in the US FDA (DMF No. : 040957),Tirzepatide API registered in the US FDA (DMF No. : 040503),

    Semaglutide API has the following three characteristics: low price, high quality, and large production capacity (tonnage). Tirzepatide API is well received favourable reviews in the pharmaceutical industry of polypeptide .



    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 5
    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 6


    Our Certificate


    Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 7 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 8 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 9 Shop Wholesale chemical peptide powder Tirzepatide CAS 2023788-19-2 API for weight loss-Detailed Image 10
    Shop 99 Purity Peptides Powder Liraglutide CAS 204656-20-2-Detailed Image 10
    FAQ

    Q: What does semaglutide do to your body?

    A: Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy.

    Q: What is the dark side of semaglutide?

    A: Pancreatitis (swelling of the pancreas) may occur while you are using this medicine. Check with your doctor right away if you have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.

    Q: Who cannot take semaglutide?

    A: Thyroid cancer or if someone in your family had thyroid cancer. An unusual or allergic reaction to semaglutide, other medications, foods, dyes, or preservatives. Pregnant or trying to get pregnant. Breast-feeding.

    Q: Why do I feel so bad on semaglutide?

    A: However, semaglutide also affects the gastrointestinal tract by increasing the amount of glucagon. This has two effects on the digestive tract. First, it slows down the movement of food through your gut, which can lead to nausea, vomiting, and diarrhea.

    Q: Can semaglutide be harmful?

    A: Nausea, vomiting, and diarrhea are the most common semaglutide side effects. But they usually subside after a few weeks of using the medication. Although rare, serious side effects are possible. Some may require immediate medical attention, such as pancreatitis and allergic reactions.

    Q: Can semaglutide damage your pancreas?

    A: Does Semaglutide Damage Your Pancreas? Semaglutide has been associated with pancreatitis, which is an inflammation of the pancreas. While pancreatitis can cause damage to the pancreas, the occurrence of this side effect due to semaglutide is considered uncommon.

    Q: Can I lose 50 lbs on semaglutide?

    A: According to clinical trials, people on a weekly semaglutide dosage can expect to lose an average of 5–10% of their body weight. Patients who were overweight lost 5.9% of their body weight after three months of weekly semaglutide injections. The average weight loss was 10.9% after 6 months of weekly injections.

    Q: Is metformin as good as semaglutide?

    A: Between these two medications, semaglutide produces more significant weight loss than metformin, but metformin tends to be a more affordable option. But patients can also opt to combine these drugs to maximize their effects with a proper treatment plan.

    Certificates
    • 99 Purity Peptides Powder Liraglutide CAS 204656-20-2 Certificates 1

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Liraglutide,Cagrilintide,PLLA facial Implant

    Location:

    NO.288,Renyang, Binglun Village, Hushi Town, Xiuyu DistrictPutian City, Fujian Province 351146, China (CHN)

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    2

    Total Annual Revenue:

    $25 million-$50 million

    Total Employees:

    201-300

    Year of Establishment:

    2019

    Certifications:

    DMF ACKNOWLEDGEMENT,Notice of GMP Compliance Inspection

    Company Profile

    Fujian Genohope Biotech Ltd., is founded by New Hope Group, a Fortune Global 500 company, together with Genovior, fomous Taiwan peptide company and now a member of the Polaris Pharma Group, as the globalized center for R&D and production of peptide products, located in the National Biotech and Health Industry Zone of Across-Strait in Putian City, Fujian Province.

    The company focuses on the research and development and production of high potency polypeptide products, targeting the global market, and provides polypeptide API/raw material and preparation products. It has built polypeptide API workshops, bio-fermentation workshops, polypeptide purification and lyophilization workshops, and multifunctional injection workshops that meet the GMP requirements of mainstream markets such as the U.S. FDA, EU EMA, Japanese PMDA, and China NMPA. With the strong support of New Hope Group, the company has introduced advanced large-scale CS-PREP® industrial preparative liquid chromatography systems, becoming one of the few polypeptide companies in the industry with a capacity of tons.

    In 2023, Genehope has been rewarded as Specialized and Novel Enterprise of Fujian Province.
    In 2023 June, the US FDA completed its first on-site inspection for Genohope.

  • Inquiry History
    28 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    United States

    Peptide Liraglutide/Victoza/Liraglutida 98% Powder 67-51-6 Weight Loss Senwayer

    1 KG Sep 30, 2023
    Jordan

    Liraglutide

    1.00 MT Sep 19, 2023
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    India

    Liraglutide

    10 G Jun 26, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.